Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Berkeley, CA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Berkeley, CA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fullerton, CA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fullerton, CA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Collins, CO
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Collins, CO
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Maitland, FL
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Maitland, FL
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sarasota, FL
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sarasota, FL
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Sunrise, FL
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sunrise, FL
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tampa, FL
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Northbrook, IL
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Northbrook, IL
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Wayne, IN
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lenexa, KA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lenexa, KA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Lexington, KY
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Lexington, KY
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Traverse City, MI
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Traverse City, MI
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
New York, NY
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Patchogue, NY
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Patchogue, NY
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Uniontown, OH
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Uniontown, OH
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Allentown, PA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Franklin, TN
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Franklin, TN
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Knoxville, TN
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Round Rock, TX
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Round Rock, TX
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Vienna, VA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Vienna, VA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Investigational Site Number 032006
mi
from
Caba,
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Investigational Site Number 032006
mi
from
Caba,
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Pasadena, CA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Des Moines, IA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Des Moines, IA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kansas City, KA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Worcester, MA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Teaneck, NJ
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Mineola, NY
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Mineola, NY
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Syracuse, NY
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Chapel Hill, NC
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Providence, RI
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Cordova, TN
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Cordova, TN
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Albuquerque, NM
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Ann Arbor, MI
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Phase IIIB-IV Long-Term Follow-up Study for Patients Who Participated in CAMMS03409
A Long-term Follow-up Study for Multiple Sclerosis Patients Who Have Completed the Alemtuzumab Extension Study (CAMMS03409)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials